255
Views
3
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Dalcetrapib – restoring belief in modulating CETP as a beneficial mechanism in cardiovascular disease

Evaluation of Fayad ZA, Mani V, Woodward M et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 2011;378:1547-59

, PhDDSc
Pages 569-573 | Published online: 13 Feb 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alyse S Goldberg & Robert A Hegele. (2012) Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib. Drug Design, Development and Therapy 6, pages 251-259.
Read now

Articles from other publishers (2)

Surojit Banerjee & Abhijit De. (2021) Pathophysiology and inhibition of cholesteryl ester transfer protein for prevention of cardiovascular diseases: An update. Drug Discovery Today 26:7, pages 1759-1764.
Crossref
. (2020) HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE. EMJ Cardiology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.